In the tumor samples, the administration of STING agonist-4 and TGF-β1 neutralizing antibody also counteracted the effect of Tregs on class I MHC molecule and PDL1 expression of MM cells (Fig. 6C). The gene discussed is STING1; the disease is neoplasm.